Suzanne Somors hormone replacement???

Options
1356715

Comments

  • LisaF
    LisaF Member Posts: 200
    edited January 2009

    Thanks for the information on Dr. Vliet.  Interesting stuff.  I'm impressed with her credentials.  Williams and Mary and Johns Hopkin are schools she's been associated with. 

    However, now I'm more confused than ever, as I just found this study.  It seems like a true study with real people and came out in March of '08, so it is fairly recent.  Wow, the more you know, the more you know you don't know.....

    High levels of estrogen associated with breast cancer recurrence

    PHILADELPHIA - Women whose breast cancer came back after treatment had almost twice as much estrogen in their blood than did women who remained cancer-free - despite treatment with anti-estrogen drugs in a majority of the women -according to researchers in a study published in the March issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

    The findings suggest that high levels of estrogen contribute to an increased risk of cancer recurrence, just as they lead to the initial development of breast cancer, said the study's lead author, Cheryl L. Rock, Ph.D., a professor in the Department of Family and Preventive Medicine at the University of California, San Diego.

    "While this makes sense, there have been only a few small studies that have looked at the link between sex hormones in the blood and cancer recurrence," she said. "This is the largest study to date and the only one to have included women taking agents such as tamoxifen to reduce estrogen's effect on cancer growth.

    "What the results mean for women who have already been treated for breast cancer is that they should do as much as they can to reduce estrogen in their blood, such as exercising frequently and keeping weight down," she added. "Taking anti-estrogen drugs like tamoxifen may not completely wipe out the hormone's effect in women who have high levels of estrogen."

    Participants from this study were drawn from the larger Women's Healthy Eating and Living Study (WHEL), a dietary intervention trial that followed 3,088 women who had been treated for early stage breast cancer but who were cancer-free at the time they enrolled. Participants were randomly assigned to one of two groups - one that ate a "normal" healthy diet and the other that ate extremely high amounts of fruits, fiber, and vegetables - and were followed for more than seven years. Breast cancer recurrence was about the same in each group, according to the results, published in 2007. Researchers interpreted the findings to mean that a normal diet that incorporates the U.S. Food and Drug Administration guidelines for recommended amounts of fruits and vegetables is sufficient.

    In the current nested case-control study, 153 WHEL participants whose cancer had recurred were matched with 153 participants who remained cancer-free. These pairs were alike in terms of tumor type, body size, age, ethnicity, use of chemotherapy and other variables. Two-thirds of the participants were using tamoxifen, Rock said.

    When they enrolled, researchers tested the women's blood for concentrations of the steroid hormones estradiol (the primary human estrogen) and testosterone. They analyzed different forms of estradiol and testosterone in the blood, such as how much was bound to transport proteins (such as to the sex hormone binding globulin, or SHBG) and how much was "free" circulating and able to enter a cell.

    Researchers found that higher estradiol concentrations, in all forms, significantly predicted cancer recurrence. Overall, women whose cancer came back had an average total estradiol concentration that was more than double the average for women who remained cancer-free. Increased levels of testosterone or SHBG levels were not associated with recurrence, contradicting the findings of several previous studies.

    Although genetic and metabolic factors likely influence the relationship between circulating sex hormones and risk of breast cancer recurrence, Rock said the study provides solid evidence that higher concentrations of estradiol in the blood contribute to risk for breast cancer recurrence.

    ###

    The Walton Family Foundation, the National Cancer Institute, and the National Institutes of Health funded the study.

    The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes nearly 27,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 70 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication and its sixth major journal, Cancer Prevention Research, is the only journal worldwide dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.

    :

  • althea
    althea Member Posts: 1,595
    edited February 2009

    >>But the U.S. Food and Drug Administration warns that these claims are "unproven" and that the products are "potentially dangerous." What's more, bio-identical hormone replacement therapy -- or "BHRT" -- is a "marketing term not recognized by FDA," the agency said.<<

    from the endocrine society...>>" 'Bioidentical hormones,' particularly estrogen and progesterone, have been promoted as safer and more effective alternatives to more traditional hormone therapies, often by people outside of the medical community. In fact, little or no scientific and medical evidence exists to support such claims... Additionally, many 'bioidentical hormone' formulations are not subject to FDA oversight and can be inconsistent in dose and purity."<<

    When I see things like this, I think it is misleading and intended to be misleading.  The claims are 'unproven' because they haven't been studied, peer reviewed and so forth.  They're not likely to be studied because the process of doing the studies is very expensive.  The prospect of making buckets of money is simply not there for bioidenticals since hormones cannot be patented.  There will be some money made, of course.  Compounding pharmacies are in business for profit. 

    Some profit simply isn't enough in recent history, as the salaries of major corporation CEOs demonstrates.  They want buckets of money, not just some.  Should women begin to use bioidentical hormones (which cannot be patented) instead of patent-holding/money-making pills derived from pregnant mares, well, that would decrease the ample flow of money into the bottomless buckets.  Best to throw in a good measure of fear and doubt just in case women might be tempted to investigate further.  

    I am continually amazed that this tactic seems to work.  Oh, we haven't studied BHRT; any claims are unproven, and besides, it might turn out (sharp intake of breath) that it might be DANGEROUS!  Well, since when is that a deterrent???  Tamoxifen can cause cataracts, blood clots, or uterine cancer.  Arimidex has bone loss as a side effect, one amongst many.  Over 100,000 deaths per year are attributable to problems associated with pharmacueticals.  That's more than double the death rate of bc each year!  

    Then they quote the expert who cautions that claims of BHRT being superior should be viewed with suspicion because all we have is testimonial claims to that effect.  And that we should be further concerned because formulas vary from person to person based on a person's need.  As if that's a bad thing??  On what planet is a standard, one size fits all formula superior to a prescription catered entirely to the needs of the individual?  And if that doesn't instill enough fear, well, heaven forbid, the compounding pharmacy might make a mistake!  To my mind, this implies that we currently have pharmacies which are flawless.  So, again, where is this planet that has drugs without consequences and pharmacies free of mistakes?  

    And in the final paragraph where we are cautioned once again that BHRT is flawed because it uses saliva testing, which fluctuates.  So if hormone levels fluctuate constantly and therefore doses for BHRT are flawed because of it, tell me again how doses for HRT are determined?  

     Well, there I go being long winded again.  I guess I could've just suggested to people who are struggling to distinguish truth from fiction that you just have to consider the source and read inbetween the lines.  

  • anondenet
    anondenet Member Posts: 715
    edited February 2009

    Hi, LisaF,

    1. What this report describes is stated in the title: higher levels of estrogen associated with breast cance recurrence.

    2. What the scientists observed is that women who recur had more estrogen and testosterone in their blood. They stated there was AN ASSOCIATION between blood levels and recurrence.

    3. Starting from this ASSOCIATION, the report then uses what are known as "weasel words" in the scientific community to establish a conjecture. The report then says "The findings SUGGEST that high levels of estrogen contribute to an increased risk of cancer recurrence." Notice they did not say "CAUSE," because the observation SUGGESTS nothing of the kind.

    The authors then go on to make an irresponsible leap, not based on evidence, but on an association, that breast cancer patients should act on the observation of this ASSOCIATION. The patients are urged to try to reduce their estrogen levels.

    4.**** In science, an ASSOCIATION in not a cause. For example, white blood cells are ASSOCIATED with infection. White blood cells do not CAUSE infection. They are a compensation mechanism, a healing response. What if you tried to reduce white blood cell levels during infection? You would be worse off. What if elevated estrogen levels were a defense mechanism and you tried to inhibit them?

    5. I'm not saying white blood cells behave the same as estrogen. But I'm saying the authors have in NO WAY demonstrated that estrogen levels cause recurrence. The authors know this which is why they had to use the weasel words to support their irresponsible call to action.

    The honest and responsible scientific approach would be for the authors to report their observations and say, "we have no idea what this association means," or in scientific language, "this association is not yet understood."

    Anom

    <

  • pip57
    pip57 Member Posts: 12,401
    edited February 2009

    I think you are ignoring the other information that makes these associations relevant even if not proven.  They have done years of testing on millions of tumour samples and been led in the direction of hormones from these studies.  Those results have led to the studies with humans. They are making 'suggestions' based on ALL the info that they have gathered so far.  I am not saying that they could be wrong.  There are millions of variations in each of our genes, lifestyles, diets, environments, etc that could 'cause' bc.  It is an enormous task to try and pin down commonalities. Perhaps they are way off base, but I don't believe that the 'alternative' sector has any better knowledge.  That is why I use a combination of tx and hope that one or a combination of these will be successful.  

  • anondenet
    anondenet Member Posts: 715
    edited February 2009

    Hi, Pretty,

    I take one study at a time. I ignore nothing. That is the only way to approach accuracy and make decisions.

    It isn't helpful or accurate to talk about the big collective "they" out there which has tested cell lines/genes/humans because you can never pinpoint what is being discussed and you can never test a hypothesis. Generalizations keep us from making progress or factfinding. Generalizations belong in barrooms where there is no pretense of getting at the truth.

    I wasn't opting for an "alternative" perspective. I don't know what that is. Evidence is evidence.

    There is not an alternative or conventional sector in science because there is no such thing as alternative biochemistry. Each study stands or falls on its own merits.

    >

  • vivre
    vivre Member Posts: 2,167
    edited February 2009

    Althea, I guess we are coming from the same angle. You laid it out just the way I am thinking. And Anom, it is true, we have to read between the lines in these studies because we have to look at what the response is expected by those who choose to gain from the outcome. My tumor was er- and pr-. It could very well be that this is how most women's hormones would read. I know that my estrogen levels would be high and progesterone low for me, because I am menopausal. So maybe they ARE wrongly surmising that this is the cause of cancer, when in fact, this is how most women's hormone levels would be anyway. I just cannot shake the feeling that we are being totally bamboozled! With Doctors like Vliet starting to make some headway, maybe the cork is about to blow off the bottle. I sure hope so. I just have a lot of anxiety that if all this stuff is true, a lot of women have been put through hell for nothing. It makes me so extremely sad.

  • AllieM22
    AllieM22 Member Posts: 464
    edited February 2009

    Wow--this was a passionate thread! Great research everyone.

    Here's what I think and I also read everything I can get my hands on. I believe from what studies I have read that for woman whose tumors are ER/PR + that estrogen hormones are likely to help 'feed' existing tumors and cause new tumors to grow. For these women (and I am one) I want to help myself in all natural ways I can--diet & exercise--as well as taking drugs that are prescribed, which for me will be tamoxifen. No drug is without a side effect--including everyday meds like ibuprofen. Side effects differ for everyone--and some drugs have higher rates of SE than others. I have talked to people and read about people on this site that do not have significant SEs from tamoxifen. I have read about many woman who do unfortunately have significant SEs--but I think if a drug might be useful in preventing a terrible disease which might be fatal, I am going to at least try it. I read feedback form a lot of women who are so worked up about what might happen that they don't even try it. 

    I certainly understand not wanting to take drugs which can have unpleasant even extreme SEs. I know some people don't trust drs or drug companies--and granted the drug companies (and the FDA) certainly have earned our mistrust. But I think dismissing all the drugs and reported studies out of hand is unwise. Just my two cents. I just think if there was a natural solution with no SEs--we would have heard out it by now--big pharm or no.

    Studies are studies--as one person said--take each one for what is studied and evaluate it that way. You can find something out there to support any theory if you want to avoid the drugs...but saying that there is nothing that supports that tamoxifen has not had good results for ER+ women is simply not true. (Again from what I've read...)

     Just my two cents! I am going to at least try it and see if I can tolerate it. I also am working to limit excess estrogen by eliminating chemicals and with my diet...our 'modern' way of life has gotten a lot of things in our bodies out of whack, and there is a lot to read on diets supporting that if you are interested.

  • vivre
    vivre Member Posts: 2,167
    edited February 2009

    One thing my doctors, and these studies that promote blocking estrogen to prevent breast cancer do not,cannot or will not answer is the question I keep asking over and over. If blocking estrogen is the key to prevention, they why does risk of breast cancer go increase with age. Why is it higher in menopausal women who have low estrogens than younger women, who have higher estrogens. There is just no logic to this. It does seem logical that the lack of progesterone, which has been proven to be protective, should be considered a better reason for concluding that breast cancer is hormone driven. So all of you who are taking tamox or arimidex, please see if you can get an answer from your doctors. Why do more women get cancer as their estrogen levels go down.? I think they have all bought the wrong bill of goods.

  • Anonymous
    Anonymous Member Posts: 1,376
    edited February 2009

    The chance of ALL cancer increases with age as the incidence of DNA damage increases with age. This is why older women should not bear children ... the longer the eggs sit in the ovaries, the more damage they incur. Same with every cell in your body.

    Estrogen has clearly been established through multiple large, multi-center, random studies as enhancing the growth of certain tumors. That doesn't mean it CAUSES cancer, but fans the fires of growth.

  • pinoideae
    pinoideae Member Posts: 1,271
    edited February 2009

    What about lack of Estrogen?  Why is breast cancer more prevalent in older women?  I am thinking, there are many different types of cancerous tumors based on one's dna. I don't understand how conclusions are made that bc tumors are "driven" by estrogen or progesterone.  Why is hormone replacement denied to women whose tumors are receptor negative?  Is hormone blocking healthier than hormone supplementing?

  • Anonymous
    Anonymous Member Posts: 1,376
    edited February 2009

    Lack of estrogen is called menopause. It's what happens naturally to your body as you age. It is not a causitive agent of neoplasms.

    They know estrogen enhances tumor growth because there are receptors on some cancer cells to which estrogen binds which turns on the replication cycle.

    Really, all this speculation and guessing is not beneficial to anyone. Study cellular biology and you will know the answers about how they know that estrogen and progesterone enhance tumor growth.

    Triple negatives and ER/PR negative people are not prescribed estrogen blockers.

    As cancer survivors, the chances of a second primary cancer is 20-40%. That is hugely higher than the average woman's chances. Pumping estrogen into a survivor is inviting trouble. A second primary can have a completely different ER/PR profile than the first cancer. It happens all the time.

  • vivre
    vivre Member Posts: 2,167
    edited February 2009

    Gee LJ, thanks for the lecture.  I think we are  smart enough to understand what menopause is. I think we have every right to ask questions and look for answers that we feel are not being answered. So far you are coming in with a lot of opinions. Do you have any research we can look at and learn from? We would like to compare apples to apples.

    DING DING Summer! You win the prize for asking the billion dollar question: Is hormone blocking healthier than hormone supplementing! This is what we would all like to know. And as long as only  the drug companies have the money to do the research, we will never know. They are not going to research something that will put them out of business. Meanwhile, we continue to be their lab rats.

  • Anonymous
    Anonymous Member Posts: 1,376
    edited February 2009

    If you are smart enough to understand what menopause is, then why do you keep asking if lack of estrogen causes cancer? Do you comprehend my response? It is estrogen receptors on tumor cells that are the problem. This is when estrogen causes problems. Since ER/PR positive cancer represents about 75% - 80% of breast cancers, then there isn't any smoking gun to suggest that estrogen waning is an issue. Aging is the issue. Gene damage causes cancer. That's not an opinion, it's fact.

    You say you have every right to ask questions, but you ask them on a forum of people who have no answers. Ask your oncologist. He actually studied cancer. Virtually no one here has.

    Further, I'm not offering "opinions" but facts. Facts are based in science and are established by scientific method. What is it that you would like me to cite? I'll be happy to provide links.

    Whom would you suggest do scientific research other than drug companies? Do you have a clue about how much money it takes to conduct research? Companies need hundreds of millions to just find compounds that might work. They need that much money again to test the compounds to see if they work, as much again to go to clinical trials to prove they work. No one is made a lab rat without their consent. Trials are conducted with volunteers.

    Why would other solutions to cancer treatment put them out of business? They are experts at making money. They would be quite delighted to find other revenue streams. And there are virtually no pharmaceutical companies who make most of their money on cancer treatments of any sort. Even I could make a profit on a cancer cure, and I"m no Wharton grad.

  • anondenet
    anondenet Member Posts: 715
    edited February 2009

    Hi Summer and Vivre,

    There are over 20 studies which found patients who used HRT after their diagnosis of cancer got less recurrence or no difference in recurrence. This information has been out there for years but ignored by most oncologists who practice only on the basis of consensus, not on the basis of the true evidence.

    From my looking at the data, 23 studies found hormones were not a problem for breast cancer patients. Only one study found a problem. Some studies include the obligatory caution in the conclusion even tho the data shows HRT is not a problem after breast cancer.

    Here are the 23 studies: www.breastcancerchoices.org/hrt

    One of the great things now is that information has become democratic. You don't have to be a doctor to access it. In fact, with your life and wellbeing at stake, you cannot afford to rely just on your doctor for information.

    <

  • pinoideae
    pinoideae Member Posts: 1,271
    edited February 2009

    One wonders why the oncs aren't seeing this information.

  • anondenet
    anondenet Member Posts: 715
    edited February 2009

    <

    My breast surgeon was aware of the studies. You'd think an oncologist could miss one study. But how could they miss 23???

    >

  • vivre
    vivre Member Posts: 2,167
    edited February 2009

    Anom, that was a great link. Thanks! I am compling a list to show my docs. Not that it will do much good, but worth a try. LOL

  • pinoideae
    pinoideae Member Posts: 1,271
    edited February 2009

    I will discuss with my doctor too.

  • Hindsfeet
    Hindsfeet Member Posts: 2,456
    edited February 2009

    LJ13, Ok...I realize that cancer cells has estrogen receptors on tumor cells. This is why doctors will not prescribe estrogen or progestrogen to breast cancer patients. They recommend taxolifin which suppresses these natural hormones. Are the possible side affects worth it? Taxolifin can cause STROKE, CANCER, and bone loss. No matter what we do there are risk.

    BUT once our cancer is surgecially removed, we no longer have a tumor with estrogen receptors. From what I have read, hormones do not cause cancer. Taking natural food based hormones help balance the body, keep it from aging ( DNA changing our cells can cause cancer... decaying cells, or our cells not being able to copy).

    Chemo, radiation and some med's changes our DNA. If hormones aid our cells to copy accurately, we might not produce defective cells that become cancerous.

    I recently had high grade multifocal dcis... lumpectomy, and now I'm looking for ways to prevent future cancer or a recurrence. For this reason I'm considering HRT. I am still on the fense. I have found all the information on this thread very helpful. Thanks to everyone for your input. It's made my search easier, and hopefully I make the right decision.

     B Barry

  • crazy4carrots
    crazy4carrots Member Posts: 5,324
    edited February 2009

    Anomdenet:  Those studies make very interesting reading.  But one caveat:  who funded the studies?  It doesn't say.  Most often pharma companies to fund them, so I'm wondering if any companies manufacturing and selling HRT were involved.

  • FloridaLady
    FloridaLady Member Posts: 2,155
    edited February 2009

    I love the thread ladies...some great research....I still want to know why triple negative and her2 is happening so much if the whole story with bc is hormones?  Are we (researchers) only smart enough to only see already known hormones and proteins?  I know that true with TN bc because they can't tell me what I have as a receptor... only tell me what I don't have??  Doesn't the thyroid also make something like 150 kinds of hormones and the mammary glands under the breast bone makes numerous hormones? How do they only know it's these two? And there has been a connection with thyroid and bc.  Also I now know they are looking at auto-immune diseases being connected to bc.  This came out at the San Antonio conference this year. How does this fit in with the whole hormone thing? 

    Bottom line if you have a recurrence can they stop progression?  Not in 95% of us.  The only known way to stop cancer is to cut it OUT!  So what do all this drugs really mean if you had good surgeon that got clean margin?  Did any of the drugs really help? chemo, hormones any of it? Do they test you hormone ladies regularly to see what your hormone levels are? My big thing is every one of us are made a little differently how do they know these drug are one size fit all? Be stage iv and do chemo and you will find out you may have the same cancer as Jane Doe but does not mean you are going to respond the same. They now have proof that minorities do not respond to chemo and other drugs the same as everyone else.  Their liver processes drugs differently. Is this taken into account?

    Sorry just had to throw a few questions out that I have thought about for a long time. Any thoughts?

    As for research dollars ask the American Cancer Society and Susan B Colman where the 100 billion the collected this year went!

    Flalady

  • FloridaLady
    FloridaLady Member Posts: 2,155
    edited February 2009

    By the way...in my research I read and was also told by my oncologist who worked at the National Cancer Institute, a drug need to only work on 10% of the population to get approved.  And these drug are only test on less that .01% of the population...

    Flalady

  • pip57
    pip57 Member Posts: 12,401
    edited February 2009

    From what I understand, the AI's are not meant so much to prevent recurrance, but to slow down or halt the growth of stray cells.  Even if you are node neg, there are other nodes and vascular routes for these cells to spread.  Just check the stage IV thread and you will see how many of them had no positive nodes but still have mets.  I would much rather deal with a recurrance than mets.  

    I also think that we too often try to simplify bc.  It is probably many different things that start it and we will never know what most of them are.  I think that the 'big bad drug companies' are doing their best to identify what they can.  When people state that they think they are just sitting on the cure I just shake my head.  Why would these companies want their best customers to die off.  The non regulated companies have much lower costs, no restrictions and make mega bucks off of desperate people.  I just think that everyone should step back and consider all the options rather than totally denounce a whole generation of science based on this theory of conspiracy. 

  • FloridaLady
    FloridaLady Member Posts: 2,155
    edited February 2009

    Cancer does not just travel through nodes is also travel through the blood. Something most doctor will not tell you. But if you have no cancer cell at the time you start chemo...chemo can not work on something that is not there! That still leaves the question how many had anything to treat after surgery.  Just three years ago you were in chemo just four months with monthly treatments.  They are not spreading it out eight to ten months. Less chemo longer.  This is because they know there are more than likely there are "no" cell right after surgery left behind.  If they are your surgeon will know most of the time from path report and nodes. The cell's must rebuild first and they are after the late guys that show up. Does hormones work they same way?  If you don't have cell that are overly sensitive to hormones do AI's help?

    As for why doctor treat the way they do...why are they only looking for long term treatment and not a cure?  Why set such a low goal?  I

    As for nodes positive...I had 56 nodes positive for cancer.  I had nine recurrences and not one bone/organ mets. THANK GOD!  Goes back to...one size does not fit all. After three major research clinic, four different onc., and nine different chemos/ 43+ tx.  I don't have to simplify bc...I know how little is really know about it.  Ask anyone who is stage iv.

    Flalady

  • pip57
    pip57 Member Posts: 12,401
    edited February 2009

    "How many had anything to treat after chemo?"  That is the million $ question.  They have no way of knowing.  So that is when the patient has to make an informed decision based on.....?  That is why we keep going back to the studies and statistics.  As for the length and dose of chemo, I was told that chemo given over a longer period of time allows the cancer cells to become resistant.  It makes sense to me.  

    I absolutely agree that we should be trying for a cure.  But if they can't figure out what the triggers are, that becomes an impossible task.  It seems like baby steps because it is.  Our bodies are very complex machines.  It amazes me that with all that can go wrong, that more doesn't. 

  • pinoideae
    pinoideae Member Posts: 1,271
    edited February 2009

    Computerized tool analyzes breast cancer tumours

    Updated Sun. Feb. 1 2009 6:10 PM ET

    The Canadian Press

    TORONTO -- Canadian researchers have developed a technology that analyzes breast cancer tumours in a new way, allowing them to predict with more than 80 per cent accuracy a patient's chance of recovering.

    The goal of the computerized tool is to eventually help doctors better target treatment to an individual patient, based on their tumour's profile.

    Called DyNeMo -- for Dynamic Network Modularity -- the system analyzes how proteins and other components within cancer cells interact with each other to form networks.

    The way the networks in cells occur can indicate how the tumour is likely to behave.

    "What you find is that those proteins actually form a network, so they're not just individual hubs doing their own thing," said co-inventor Marc Wrana, a senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto.

    "They're all interlinked, in the same way humans are interlinked in a social network."

    "Our hope with this technology is to eventually provide individualized analysis to breast cancer patients and their oncologists so that they are better informed and empowered to select a treatment best suited to them."

    That could mean using certain drugs instead of others, he explained.

    Co-inventor Ian Taylor, a PhD candidate in molecular genetics in Wrana's lab, said DyNeMo is intended to add another piece of information to other prognostic technologies used by doctors to determine the size, stage, grade and other traits of a woman's breast tumour.

    "This technology doesn't replace those, but it does complement them ... so we have more accurate predictions," he said, noting that as worldwide studies on protein networks accrue, "we expect our accuracy of prediction will increase."

    The researchers are looking for partners in the biotech or pharmaceutical industries to commercialize the product, said Wrana, who hopes it will be in widespread use for breast cancer patients within five years.

    They also plan to apply the technology to other types of cancer to see if it could predict a patient's response to particular drugs before treatment is chosen. Cellular networks may play a critical role in other diseases, as well.

    "Our idea is that these global network changes might not be just important in cancer, but other kinds of complex diseases, such as inflammatory bowel disease," Wrana said.

    Marc Vidal, an associate professor of genetics at Harvard Medical School, called the Toronto research an important step in the evolution of personalized medicine.

    "They made a really important discovery in cancer research," he said from Boston.

    Vidal said the rapidly evolving field of network biology suggests that it is not a person's individual DNA that matters so much, but how that DNA makes products like proteins and how those products interact with each other "in amazingly complex ways."

    "That's what creates a cancer cell, that's what creates a cancer cell that will respond -- or not -- to a particular compound (drug)."

    Vidal said the exciting aspect of the research is the use of network biology to analyze and better understand cancer cells.

    While that won't lead to fully personalized treatment right away, "it's definitely a great foot in the door in that direction."

  • althea
    althea Member Posts: 1,595
    edited February 2009

    barry, I believe bone loss is a side effect of aromatase inhibitors, such as arimidex, rather than tamoxifen.  As I recall what I learned about tamoxifen is that it allows our bodies to continue making estrogen, and the protection it offers is to bind with the receptors in our breast. 

    LJ13, I don't know what a neoplasm is nor have I studies cellular biology, but I know that I don't need a medical degree to understand that mistrust of so-called experts by and large is earned and deserved.  And I've done plenty of studying on my own to arrive at that conclusion.  

    I truly would love to have medical professionals that I can trust, that I can depend upon to know a whole lot more than I do about medicine, biology, disease and treatments.  My oncologist doesn't even test my hormone levels.  When I asked one of his nurses why not, I was told that they 'only test for things that are cancer-related.'  OK, so I had a tumor that fed on estrogen, but testing my estrogen levels is not cancer related.  Who came up with that reasoning??  Probably an insurance company.  When I asked the same question to my oncologist directly, his response was 'that information isn't helpful.'  To date my estrogen levels have been tested once, and that was three years post-dx.  

    I don't think anyone here is claiming to have all the answers.  We're talking about what the answers might be someday.  There's a lot of conflicting information out there when you venture outside the allopathic realm.  I doubt this section of bc.org would exist if any of us were satisfied with what we found at our oncologists' offices.  

  • Rosemary44
    Rosemary44 Member Posts: 2,660
    edited February 2009

    Not for nothing, but I was reading a few of those studies from breast cancer choices, and I don't see what the original dx of those ladies were who participated in the study.  Are they ER+?  They seem to be testing ladies who either took an HRT before dx or didn't.  I didn't read them all yet, but so far none of the studies are saying if the women were dx'd with estrogen positive tumors. 

    I'll read on.

  • anondenet
    anondenet Member Posts: 715
    edited February 2009

    In the O'meara study 56% percent of the participants were hormone receptor positive.

    <

  • vivre
    vivre Member Posts: 2,167
    edited February 2009

    Althea, that was an interesting comment that you made about tamox because that goes along with the effects of I3C, which my blood tests are proof of. It inhibits the ability for the estrogens to bind to cancer cells. After a year on I3C, my hormone levels did not change drastically. They did go down, but I attribute that to weight loss, exercise and diet. However, my sex hormone globulin number went from 127, which was considered very high to 69, which is considered in the reference range. I was taking 200mg of I3C a day and I am now upping it to 400-500 to see if I can lower this number even more. My doctor says that this is one of the most important numbers to look at. As the quote from Dr Reiss that I posted earlier says, I3C may have the same effects as tamox with no side effects(I am paraphrasing here).

Categories